{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:22:17Z","timestamp":1792437737236,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1993,10,1]],"date-time":"1993-10-01T00:00:00Z","timestamp":749433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[1993,10]]},"DOI":"10.1007\/bf00914195","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T03:09:25Z","timestamp":1104548965000},"page":"573-582","source":"Crossref","is-referenced-by-count":94,"title":["Selective inhibition of group II phospholipase A2 by quercetin"],"prefix":"10.1007","volume":"17","author":[{"given":"Mats","family":"Lindahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Tagesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/0006-2952(87)90512-0","volume":"36","author":"J. Chang","year":"1987","unstructured":"Chang, J., J. H. Musser, andH. McGregor. 1987. Phospholipase A2: Function and pharmacological regulation.Biochem. Pharmacol. 36:2429?2436.","journal-title":"Biochem. Pharmacol."},{"key":"CR2","first-page":"1351","volume":"15","author":"W. Pruzanski","year":"1988","unstructured":"Pruzanski, W., E. C. Keystone, B. Sternby, C. Bombardier, K. M. Snow, andP. Vadas. 1988. Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis.J. Rheumatol. 15:1351?1355.","journal-title":"J. Rheumatol."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF02028289","volume":"24","author":"P. Vadas","year":"1988","unstructured":"Vadas, P., W. Pruzanski, andE. Stefanski. 1988. Extracellular phospholipase A2: Causative agent in circulatory collapse of septic shock?Agents Actions 24:320?325.","journal-title":"Agents Actions"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/S0021-9258(18)52293-6","volume":"266","author":"R. M. Crowl","year":"1991","unstructured":"Crowl, R. M., T. J. Stoller, R. R. Conroy, andC. R. Stoner. 1991. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response.J. Biol. Chem. 266:2647?2651.","journal-title":"J. Biol. Chem."},{"key":"CR5","first-page":"143","volume":"12","author":"W. Pruzanski","year":"1991","unstructured":"Pruzanski, W., andP. Vadas. 1991. Phospholipase A2-a mediator between proximal and distal effectors of inflammation.Immunol. Today 12:143?146.","journal-title":"Immunol. Today"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02109500","volume":"31","author":"F. F. Davidson","year":"1990","unstructured":"Davidson, F. F., andE. A. Dennis. 1990. Evolutionary relationships and implications for the regulation of phospholipase A2 from venom to human secreted forms.J. Mol. Evol. 31:228?238.","journal-title":"J. Mol. Evol."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/S0021-9258(18)83616-X","volume":"264","author":"R. M. Kramer","year":"1989","unstructured":"Kramer, R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. T. Tizard, andR, B. Pepinsky. 1989. Structure and properties of a human nonpancreatic phospholipase A2.J. Biol. Chem. 264:5768?5774.","journal-title":"J. Biol. Chem."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1016\/S0021-9258(18)60626-X","volume":"263","author":"T. Ono","year":"1988","unstructured":"Ono, T., H. Tojo, S. Kuramitsu, H. Kagamiyama, andM. Okamoto. 1988. Purification and characterization of a membrane-associated phospholipase A2 from rat spleen. Its comparison with a cytosolic phospholipase A2 S-1.J. Biol. Chem. 263:5732?5738.","journal-title":"J. Biol. Chem."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-5793(90)81042-M","volume":"273","author":"T. Nakano","year":"1990","unstructured":"Nakano, T., andH. Arita. 1990. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid.FEBS Lett. 273:23?26.","journal-title":"FEBS Lett."},{"key":"CR10","first-page":"281","volume":"58","author":"Y. Matsuda","year":"1987","unstructured":"Matsuda, Y., M. Ogawa, T. Shibata, K. Nakaguchi, J.-I. Nishijima, C. Wakasugi, andT. Mori. 1987. Distribution of immunoreactive pancreatic phospholipase A2 (IPPL-2) in various human tissues.Res. Commun. Chem. Pathol. Pharmacol. 58:281?284.","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1016\/S0021-9258(19)39203-8","volume":"265","author":"G. W. Wright","year":"1990","unstructured":"Wright, G. W., C. E. Ooi, J. Weiss, andP. Elsbach. 1990. Purification of a cellular (granulocyte) and extracellular (serum) phospholipase A2 that participate in the destruction ofEscherichia coli in a rabbit inflammatory exudate.J. Biol. Chem. 265:6675?6681.","journal-title":"J. Biol. Chem."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/gut.33.7.914","volume":"33","author":"T. Minami","year":"1992","unstructured":"Minami, T., H. Tojo, Y. Shinomura, S. Tarui, andM. Okamoto. 1992. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: Its correlation with disease activity of Crohn's disease and ulcerative colitis.Gut 33:914?921.","journal-title":"Gut"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0024-3205(92)90186-S","volume":"50","author":"P. Vadas","year":"1992","unstructured":"Vadas, P., K. Scott, G. Smith, I. Rajkovic, E. Stefanski, B. D. Schouten, R. Singh, andW. Pruzanski. 1992. Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock.Life Sci. 50:807?811.","journal-title":"Life Sci."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02924166","volume":"10","author":"M. Kitigawa","year":"1991","unstructured":"Kitigawa, M., T. Hayakawa, T. Kondo, T. Shibata, Y. Sakai, H. Sobajima, H. Ishiguro, M. Tanikawa, Y. Nakae, S. Kameya, andA. Noda. 1991. Elevation of serum phospholipase A2 in patients at an intensive care unit.Int. J. Pancreatol. 10:279?286.","journal-title":"Int. J. Pancreatol."},{"key":"CR15","first-page":"59","volume":"18","author":"L. A. Marshall","year":"1991","unstructured":"Marshall, L. A., J. Bauer, M. L. Sung, andJ. Y. Chang. 1991. Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2.J. Rheumatol. 18:59?65.","journal-title":"J. Rheumatol."},{"key":"CR16","first-page":"157","volume":"24","author":"D. Mobilio","year":"1989","unstructured":"Mobilio, D., andL. A. Marshall. 1989. Recent advances in the design and evaluation of inhibitors of phospholipase A2.Annu. Rep. Med. Chem. 24:157?166.","journal-title":"Annu. Rep. Med. Chem."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0005-2760(72)90008-2","volume":"260","author":"P. Patriarca","year":"1972","unstructured":"Patriarca, P., S. Beckerdite, andP. Elsbach. 1972. Phospholipase and phospholipid turnover inEscherichia coli spheroplasts.Biochim. Biophys. Acta 260:593?600.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0020-711X(91)90108-Y","volume":"23","author":"M. Lindahl","year":"1991","unstructured":"Lindahl, M., C. de Wit, B. Westr\u00f6m, H. von Schenck, andC. Tagesson. 1991. Demonstration of a phospholipase A2 inhibitor in human plasma and in plasma from the european hedgehog (Erinaceus europaeus).Int. J. Biochem. 23:287?292.","journal-title":"Int. J. Biochem."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF01966206","volume":"19","author":"P. Vadas","year":"1986","unstructured":"Vadas, P., E. Stefanski, andW. Pruzanski. 1986. Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock.Agents Actions 19:194?202.","journal-title":"Agents Actions"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0005-2760(89)90050-7","volume":"1005","author":"M. Lindahl","year":"1989","unstructured":"Lindahl, M., H. von Schenck, andC. Tagesson. 1989. Isolation and characterization of phospholipase A2 from rat lung with affinity chromatography and two-dimensional gel electrophoresis.Biochim. Biophys. Acta 1005:282?288.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0025-7125(16)31199-3","volume":"67","author":"D. P. Nicholson","year":"1983","unstructured":"Nicholson, D. P. 1983. Corticosteroids in treatment of septic shock and the adult respiratory distress syndrome.Med. Clin. North Am. 67:717?724.","journal-title":"Med. Clin. North Am."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00916090","volume":"8","author":"J. Chang","year":"1984","unstructured":"Chang, J., M. D. Skowronek, M. L. Cherney, andA. J. Lewis. 1984. Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations.Inflammation 8:143?155.","journal-title":"Inflammation"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0041-0101(87)90286-8","volume":"25","author":"B. S. Vishwanath","year":"1987","unstructured":"Vishwanath, B. S., R. M. Kini, andT. V. Gowda. 1987. Characterization of three edemainducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid.Toxicon 25:501?515.","journal-title":"Toxicon"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0041-0101(87)90156-5","volume":"25","author":"B. S. Vishwanath","year":"1987","unstructured":"Vishwanath, B. S., A. G. A. Rao, andT. V. Gowda. 1987. Interaction of phospholipase A2 fromVipera russelli venom with aristolochic acid: A circular dichroism study.Toxicon 25:939?946.","journal-title":"Toxicon"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(89)90299-3","volume":"1001","author":"M. D. Rosenthal","year":"1989","unstructured":"Rosenthal, M. D., B. S. Vishwanath, andR. C. Franson. 1989. Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils.Biochim. Biophys. Acta 1001:1?8.","journal-title":"Biochim. Biophys. Acta"},{"key":"CR26","first-page":"155","volume-title":"The Phospholipases. Handbook of Lipid ReseArch. Vol. 5","author":"M. Waite","year":"1987","unstructured":"Waite, M. 1987. Pancreatic and snake venom phospholipases A2.In The Phospholipases. Handbook of Lipid ReseArch. Vol. 5. D. J. Hanahan, editor. Plenum Press, New York. 155?190."},{"key":"CR27","series-title":"Link\u00f6ping University Medical Dissertations","volume-title":"Phospholipase A2 activation and inflammatory reactions in the lung","author":"M. Lindahl","year":"1990","unstructured":"Lindahl, M. 1990. Phospholipase A2 activation and inflammatory reactions in the lung. Link\u00f6ping University Medical Dissertations No. 323, Link\u00f6ping, Sweden."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF01972839","volume":"27","author":"W. Calhoun","year":"1989","unstructured":"Calhoun, W., J. Yu, A. Sung, T. T. Chau, L. A. Marshall, B. M. Weichman, andR. P. Carlson. 1989. Pharmacologic modulation of D-49 phospholipase A2-induced paw edema in the mouse.Agents Actions 27:418?421.","journal-title":"Agents Actions"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000233694","volume":"76","author":"C. Lanni","year":"1985","unstructured":"Lanni, C., andE. L. Becker. 1985. Inhibition of neutrophil phospholipase A2 by p-bromophenacyl bromide, nordihydroguaiaretic acid, 5,8,11,14-eicostetetrayenoic acid and quercetin.Int. Arch. Allergy. Appl. Immun. 76:214?217.","journal-title":"Int. Arch. Allergy. Appl. Immun."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF01965048","volume":"25","author":"A. A. Fawzy","year":"1988","unstructured":"Fawzy, A. A., B. S. Vishwanath, andR. C. Franson. 1988. Inhibition of human nonpancreatic phospholipase A2 by retinoids and flavonoids. Mechanism of action.Agents Actions 25:394?400.","journal-title":"Agents Actions"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF01711353","volume":"67","author":"M. Baur","year":"1989","unstructured":"Baur, M., T. O. Schmid, andB. Landauer. 1989. Role of phospholipase A in multiorgan failure with special reference to ARDS and acute renal failure (ARF).Klin. Wochenschr. 67:196?202.","journal-title":"Klin. Wochenschr."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF01711341","volume":"67","author":"G. E. Hoffmann","year":"1989","unstructured":"Hoffmann, G. E., andW. G. Guder. 1989. Serum phospholipase-regulatory and pathophysiological aspects.Klin. Wochenschr. 67:144?148.","journal-title":"Klin. Wochenschr."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00917456","volume":"14","author":"P. Vadas","year":"1990","unstructured":"Vadas, P., W. Pruzanski, E. Stefanski, andB. Sternby. 1990. Compartmental heterogeneity of soluble phospholipase A.Inflammation 14:173?183.","journal-title":"Inflammation"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/clinchem\/34.6.1052","volume":"34","author":"J. U. Eskola","year":"1988","unstructured":"Eskola, J. U., T. J. Nevalainen, andP. Kortesuo. 1988. Immunoreactive pancreatic phospholipase A2 and catalytically active phospholipase A2 in serum from patients with acute pancreatitis.Clin. Chem. 34:1052?1054.","journal-title":"Clin. Chem."},{"key":"CR35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00917507","volume":"15","author":"W. Pruzanski","year":"1991","unstructured":"Pruzanski, W., S. Saito, E. Stefanski, andP. Vadas. 1991. Comparison of group I and II soluble phospholipase A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.Inflammation 15:127?135.","journal-title":"Inflammation"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1016\/S0021-9258(18)42711-1","volume":"267","author":"K. Hanasaki","year":"1992","unstructured":"Hanasaki, K., andH. Arita. 1992. Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. Its cellular and tissue distribution.J. Biol. Chem. 267:6414?6420.","journal-title":"J. Biol. Chem."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-5793(91)81440-J","volume":"294","author":"M. Murakami","year":"1991","unstructured":"Murakami, M., I. Kudo, andK. Inoue. 1991. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2.FEBS Lett. 294:247?251.","journal-title":"FEBS Lett."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00914195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00914195\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00914195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T07:52:57Z","timestamp":1682927577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00914195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,10]]}},"alternative-id":["BF00914195"],"URL":"https:\/\/doi.org\/10.1007\/bf00914195","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,10]]}}}